Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MOREB Cell Maturation Antigen (BCMA), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17),is encoded by TNFRSF17 gene in human. It is a transmembrane signaling protein preferentially expressed on plasma cells. It is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF). Its ligands including BAFF and A Proliferation Inducing Ligand (APRIL). BCMA is involved in JNK and NF-kB activation pathways that induce B-cell development and autoimmune responses. BCMA has been implicated in autoimmune disorders as well as B-lymphocyte malignancies, leukemia, lymphomas, and multiple myeloma.
Associated Disease
Loading...| CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
| CAR-T-1-L335-2 | Anti-BCMA scFv h(CD28) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD28 | Lentiviral | T cell | |
| CAR-T-1-L335-G | Anti-BCMA scFv h(FcεRIγ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-FcεRIγ | Lentiviral | T cell | |
| CAR-T-1-L335-Z | Anti-BCMA scFv h(CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD3ζ | Lentiviral | T cell | |
| CAR-T-2-L335-2G | Anti-BCMA scFv h(CD28-FcεRIγ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD28-FcεRIγ | Lentiviral | T cell | |
| CAR-T-2-L335-2Z | Anti-BCMA scFv h(CD28-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD28-CD3ζ | Lentiviral | T cell | |
| CAR-T-2-L335-4G | Anti-BCMA scFv h(CD4-FcεRIγ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD4-FcεRIγ | Lentiviral | T cell | |
| CAR-T-2-L335-4Z | Anti-BCMA scFv h(CD4-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD4-CD3ζ | Lentiviral | T cell | |
| CAR-T-2-L335-8Z | Anti-BCMA scFv h(CD8-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD8-CD3ζ | Lentiviral | T cell | |
| CAR-T-2-L335-BZ | Anti-BCMA scFv h(41BB-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-T-2-L335-CZ | Anti-BCMA scFv h(b2c-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-b2c-CD3ζ | Lentiviral | T cell | |
| CAR-T-3-L335-2BZ | Anti-BCMA scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC041 | Anti-BCMA (C12A3.2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | C12A3.2 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | |
| CAR-LC135 | Anti-BCMA (P5A2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | P5A2 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC136 | Anti-BCMA (A02_Rd4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | A02_Rd4 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC002 | Anti-BCMA (J6M0)h(41BB-CD3ζ) CAR, pCDCAR1 | Human | J6M0 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC260 | Anti-BCMA (C12A3.2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C12A3.2 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-T-3-L335-2XZ | Anti-BCMA scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1 | Human | MM0108-3D44 | Rat | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell | |
| CAR-LC042 | Anti-BCMA (C11D5.3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | C11D5.3 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | |
| CAR-LC137 | Anti-BCMA (P5C1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | P5C1 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC138 | Anti-BCMA (C01_Rd4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C01_Rd4 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC139 | Anti-BCMA (COMBO_Rd4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | COMBO_Rd4 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC140 | Anti-BCMA (L3PY/H2DY) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | L3PY/H2DY | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC043 | Anti-BCMA (C11D5.3) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C11D5.3 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC044 | Anti-BCMA (C11D5.3) h(OX40-CD3ζ) CAR, pCDCAR1 | Human | C11D5.3 | Mouse | scFv-OX40-CD3ζ | Lentiviral | T cell | |
| CAR-LC045 | Anti-BCMA (C11D5.3) h(41BB-OX40-CD3ζ) CAR, pCDCAR1 | Human | C11D5.3 | Mouse | scFv-41BB-OX40-CD3ζ | Lentiviral | T cell | |
| CAR-MZ014 | Anti-BCMA (C13F12.1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | C13F12.1 | Humanized | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-MZ122 | Anti-BCMA (11D5-3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 11D5-3 | Mouse | scFv-CD28-CD3ζ | Retroviral | T cell | |
| CAR-LC261 | Anti-BCMA (BC50) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | BC50 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC262 | Anti-BCMA (BC30) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | BC30 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-LC285 | Anti-TNFRSF17 h(CD28-OX40-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | Human | dAPRIL-CD28-OX40-CD3ζ | Retroviral | T cell | ||
| CAR-LC286 | Anti-TNFRSF17 h(CD8STK-CD28-OX40-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | Human | dAPRIL-CD8STK-CD28-OX40-CD3ζ | Retroviral | T cell | ||
| CAR-LC141 | Anti-BCMA (P6AP-V1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | P6AP-V1 | Human | scFv-41BB-CD3ζ | Lentiviral | T cell | |
| CAR-YF175 | Anti-BCMA (CBL-YF057) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF057 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF115 | Anti-BCMA (J22.9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | J22.9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF176 | Anti-BCMA (CBL-YF057) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF057 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF131 | Anti-BCMA (7G2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7G2 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF132 | Anti-BCMA (7G2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7G2 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF133 | Anti-BCMA (7A12) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7A12 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF134 | Anti-BCMA (7A12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7A12 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-YF135 | Anti-BCMA (23F10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 23F10 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
